Finance

Lists
Why is 002728 down 2.11%?
Dive Deeper
002728:SHE
Teyi Pharmaceutical Group Co Ltd
CNÂ¥8.34
-2.11%
(-0.18) 1D
Nov 18, 3:04:51 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002728...
Open
CNÂ¥8.50
High
CNÂ¥8.59
Low
CNÂ¥8.34
Mkt. cap
4.37B
Avg. vol.
23.11M
Volume
11.39M
Dividend
1.80%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
62.48
52-wk high
CNÂ¥15.05
52-wk low
CNÂ¥7.66
EPS
CNÂ¥0.13
Shares outstanding
513.31M
No. of employees
1K
Open
CNÂ¥8.50
High
CNÂ¥8.59
Low
CNÂ¥8.34
Mkt. cap
4.37B
Avg. vol.
23.11M
Volume
11.39M
Dividend
1.80%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
62.48
52-wk high
CNÂ¥15.05
52-wk low
CNÂ¥7.66
EPS
CNÂ¥0.13
Shares outstanding
513.31M
No. of employees
1K
News stories
From web sources and news partners
About Teyi Pharmaceutical Group Co Ltd
CEO-
Employees1.43K
FoundedMay 23, 2002
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
232.68M
209.87M
183.45M
230.22M
Cost of goods sold
123.26M
81.88M
87.55M
98.31M
Cost of revenue
123.26M
81.88M
87.55M
98.31M
Research and development expenses
14.19M
9.25M
11.05M
12.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
83.64M
85.27M
75.71M
97.36M
Operating expense
102.76M
93.09M
88.23M
113.84M
Total operating expenses
226.01M
174.97M
175.78M
212.15M
Operating income
6.67M
34.91M
7.67M
18.07M
Other non operating income
604.89K
-33.22K
-206.21K
-71.45K
EBT including unusual items
7.45M
35.14M
7.17M
18.51M
EBT excluding unusual items
7.29M
35.61M
7.09M
18.81M
Income tax expense
-9.00M
9.37M
1.83M
168.20K
Effective tax rate
-120.80%
26.67%
25.48%
0.91%
Other operating expenses
4.17M
-340.24K
1.34M
1.60M
Net income
16.45M
25.76M
5.34M
18.34M
Net profit margin
7.07%
12.28%
2.91%
7.97%
Earnings per share
-
-
-
-
Interest and investment income
601.98K
1.52M
859.16K
1.24M
Interest expense
-579.51K
-775.84K
-1.24M
-430.78K
Net interest expenses
22.46K
742.40K
-376.54K
811.84K
Depreciation and amortization charges
-
-
-
-
EBITDA
24.12M
52.36M
26.35M
35.53M
Gain or loss from assets sale
68.45K
-
-802.00
802.00
Upcoming events
AI content may include mistakes. Learn more
Google apps